Abstract
Traditional pathogenic diagnosis presents defects such as a low positivity rate, inability to identify uncultured microorganisms, and time-consuming nature. Clinical metagenomics next-generation sequencing can be used to detect any pathogen, compensating for the shortcomings of traditional pathogenic diagnosis. We report third-generation long-read sequencing results and second-generation short-read sequencing results for ascitic fluid from a patient with liver ascites and compared the two types of sequencing results with the results of traditional clinical microbial culture. The distribution of pathogenic microbial species revealed by the two types of sequencing results was quite different, and the third-generation sequencing results were consistent with the results of traditional microbial culture, which can effectively guide subsequent treatment. Short reads, the lack of amplification and enrichment to amplify signals from trace pathogens, and host background noise may be the reasons for high error in the second-generation short-read sequencing results. Therefore, we propose that long-read-based rRNA analysis technology is superior to the short-read shotgun-based metagenomics method in the identification of pathogenic bacteria.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
We use body fluid specimens, and we have not conducted human experiments.
Funding Statement
This study was sponsored by Clinical Medicine Center Construction Program of Fuzhou, Fujian, P.R.C. [Grant numbers: 2018080306], Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C. and Health research innovation team cultivation project of Fuzhou [Grant numbers: 2019-S-w14], Social Development Project of Fuzhou Science and Technology Bureau [Grant numbers: 2019-SZ-42].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical approval of this study was provided by the Institutional Ethical Committee of the Faculty of Medicine, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fujian, China (No. 2019_057_01).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
jun{at}fzu.edu.cn, 15960102808{at}163.com, liubaorong747{at}163.com
Data Availability
All raw data was uploaded to the NCBI-SRA database under the accession number of PRJNA661722.
